featured
Cardiovascular Effects of Pioglitazone in T2DM
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Research and Clinical Practice
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pioglitazone Treatment and Cardiovascular Event and Death in Subjects With Type 2 Diabetes Without Established Cardiovascular Disease (JDDM 36)
Diabetes Res. Clin. Pract. 2015 Sep 01;109(3)485-492, H Yokoyama, S Araki, K Kawai, K Hirao, M Oishi, K Sugimoto, H Sone, H Maegawa, A KashiwagiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.